These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4015083)

  • 21. Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community.
    Espie CA; Gillies JB; Montgomery JM
    J Ment Defic Res; 1990 Aug; 34 ( Pt 4)():351-60. PubMed ID: 2398491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis A in an institution for the mentally retarded in an intermediate endemicity area: influence of age length of institutionalization.
    Gil A; González A; Dal-Ré R; Dominguez V; Ortega P; Barrio JL; Aguilar L
    J Infect; 1999 Mar; 38(2):120-3. PubMed ID: 10342653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotropic drug use in older developmentally disabled with behavioral difficulties.
    Harper DC; Wadsworth JS; Michael AL
    Res Dev Disabil; 1989; 10(1):53-60. PubMed ID: 2928579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of polypharmacy for epilepsy in an institution for the retarded.
    Bennett HS; Dunlop T; Ziring P
    Dev Med Child Neurol; 1983 Dec; 25(6):735-7. PubMed ID: 6653906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of and determinants for psychotropic drug use in an institution for the mentally retarded.
    Linaker OM
    Br J Psychiatry; 1990 Apr; 156():525-30. PubMed ID: 1974820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mono- or polypharmacotherapy in institutionalized epileptic children with severe mental retardation? A team approach for optimizing antiepileptic therapy.
    Ferngren H; Akerström I; Rane A
    Acta Paediatr Scand; 1991 Apr; 80(4):458-65. PubMed ID: 2058396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric illness among the mentally retarded. A swedish population study.
    Göstason R
    Acta Psychiatr Scand Suppl; 1985; 318():1-117. PubMed ID: 3893045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavior disorders in persons with mental retardation receiving antipsychotic medication.
    Ono Y
    Res Dev Disabil; 1998; 19(2):123-30. PubMed ID: 9547524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of BR-16 A (Mentat) in cognitive and behavioural dysfunction of mentally retarded children--a placebo-controlled study.
    Dave UP; Chauvan V; Dalvi J
    Indian J Pediatr; 1993; 60(3):423-8. PubMed ID: 8253492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
    Clarke DJ; Kelley S; Thinn K; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
    Jacobson JW
    Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A decade of modern epilepsy therapy in institutionalized mentally retarded patients.
    Pellock JM; Hunt PA
    Epilepsy Res; 1996 Nov; 25(3):263-8. PubMed ID: 8956925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children.
    Tolman KG; Jubiz W; Sannella JJ; Madsen JA; Belsey RE; Goldsmith RS; Freston JW
    Pediatrics; 1975 Jul; 56(1):45-50. PubMed ID: 1161362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypocalcaemia and secondary hyperparathyroidism in institutionalised mentally-retarded patients receiving anticonvulsant drugs: a survey of 292 patients.
    Maclay E; Hadden DR; McIlrath EM; Nesbitt GS
    Ulster Med J; 1978; 47(1):63-72. PubMed ID: 653898
    [No Abstract]   [Full Text] [Related]  

  • 36. Appropriate and inappropriate use of psychotherapeutic medications for institutionalized mentally retarded persons.
    Bates WJ; Smeltzer DJ; Arnoczky SM
    Am J Ment Defic; 1986 Jan; 90(4):363-70. PubMed ID: 3946473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment with anti-epileptic drugs--a survey of mentally handicapped adults].
    Meins W
    Rehabilitation (Stuttg); 1989 Feb; 28(1):10-4. PubMed ID: 2564691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication use among Australian adults with intellectual disability in primary healthcare settings: a cross-sectional study.
    Doan TN; Lennox NG; Taylor-Gomez M; Ware RS
    J Intellect Dev Disabil; 2013 Jun; 38(2):177-81. PubMed ID: 23550741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compliance for anticonvulsant medication in an institution for mentally retarded.
    Alvarez N
    Clin Electroencephalogr; 1982 Apr; 13(2):103-7. PubMed ID: 7094351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
    Thinn K; Clarke DJ; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.